(E)-4-(3-(5-bromo-4-hydroxy-2-methoxyphenyl)acryloyl)phenyl benzoate | 1313892-58-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: (E)-4-(3-(5-bromo-4-hydroxy-2-methoxyphenyl)acryloyl)phenyl benzoate
• 英文别名: [4-[(E)-3-(5-bromo-4-hydroxy-2-methoxyphenyl)prop-2-enoyl]phenyl] benzoate
• CAS: 1313892-58-8
• 化学式: C₂₃H₁₇BrO₅
• 分子量: 453.289
• InChiKey: RQXYHTXFRAPVMA-FMIVXFBMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  5-bromo-2-methoxy-4-(tetrahydro-2H-pyran-2-yloxy)benzaldehyde 在 吡啶 、 盐酸 、 水 、 potassium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 水 为溶剂， 反应 48.0h， 生成 (E)-4-(3-(5-bromo-4-hydroxy-2-methoxyphenyl)acryloyl)phenyl benzoate
  参考文献：
  名称：

  Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors

  摘要：

  A series of bromo-retrochalcones was designed, synthesized and evaluated as PTP1B inhibitors based on licochalcone A and E. Compounds 6, 12, 13, 14, 25, 36, 37, 39, and 41 showed potent inhibitory effects against PTP1B, and compound 37, the most potent among the series, had an IC(50) value of 1.9 mu M, about two-fold better than that of the positive control, ursolic acid. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.04.057

文献信息

• Chalcone derivatives as novel, potent and selective inhibitors against human Notum: Structure–activity relationships and biological evaluations
  作者：Jin-Hui Shi、Bei Zhao、Li-Lin Song、Yu-Qing Song、Meng-Ru Sun、Tian Tian、Hong-Yu Chen、Yun-Qing Song、Jian-Ming Sun、Guang-Bo Ge

  DOI：10.1016/j.cclet.2023.108405

  日期：2023.3

  (IC50 = 3.6 nmol/L), good selectivity, excellent chemical stability and suitable metabolic stability. Further investigations showed that B11 acted as a competitive inhibitor of hNotum, while this agent (5 µmol/L) significantly weaken the migration abilities of colorectal cancer cells. Collectively, this study deciphers the SARs of chalcones as hNotum inhibitors and reports a novel and potent hNotum inhibitor

  人类 Notum (hNotum) 抑制剂可用于治疗 Wnt 信号相关疾病，包括结直肠癌。在此，设计并合成了两个系列的查耳酮衍生物，旨在寻找选择性且有效的 hNotum 抑制剂。构效关系（SAR）研究表明，A环上的2-甲氧基和5-溴取代显着增强了抗hNotum作用，而B环上的4'-乙氧基和3'-烷基取代有利于hNotum抑制。在所有测试的查耳酮中，B11表现出最有效的抗Notum作用（IC 50  = 3.6 nmol/L）、良好的选择性、优异的化学稳定性和合适的代谢稳定性。进一步的研究表明，B11作为hNotum的竞争性抑制剂，而该剂（5 µmol/L）显着削弱结直肠癌细胞的迁移能力。总的来说，这项研究破译了查尔酮作为 hNotum 抑制剂的 SAR，并报告了一种新型有效的 hNotum 抑制剂，对结直肠癌细胞具有抗迁移作用，为开发新型抗癌药物提供了一种有前途的先导化合物。
• Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors
  作者：Zhiguo Liu、Woojung Lee、Su-Nam Kim、Goo Yoon、Seung Hoon Cheon

  DOI：10.1016/j.bmcl.2011.04.057

  日期：2011.6

  A series of bromo-retrochalcones was designed, synthesized and evaluated as PTP1B inhibitors based on licochalcone A and E. Compounds 6, 12, 13, 14, 25, 36, 37, 39, and 41 showed potent inhibitory effects against PTP1B, and compound 37, the most potent among the series, had an IC(50) value of 1.9 mu M, about two-fold better than that of the positive control, ursolic acid. (C) 2011 Elsevier Ltd. All rights reserved.